Fritextsökning
Innehållstyper
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Diamyds vd går till Index
Från och med april ska Peter Zerhouni leda forskningsbolaget, som bland annat utvecklar läkemedel mot inflammatoriska tarmsjukdomar.
-
Recipharm satsar på Israel
Inleder samarbete med Hadasit för att kunna erbjuda kombinerade kliniska, biologiska och kemiska tjänster i Mellanöstern.
-
Orexo stämmer Actavis
Uppsalabolaget har inlämnat en stämningsansökan mot Actavis för patentintrång avseende Abstral i USA.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Första priset efter rekorddonationen
I maj 2016 donerade Bengt Sjöberg 2 miljarder kronor - en av de största donationerna i svensk historia. Nu delas det första priset i donationens namn ut. Sjöber...
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
GSK:s ebolavaccin får snabbspår i FDA
Nu inleder bolaget patientstudier i friska frivilliga.
-
De får högst forskningsbidrag av Vetenskapsrådet
Jan Nilsson, Leif Groop och Jonas Frisén ska driva de projekt som fick högst bidrag i årets bidragsutdelning inom medicin och hälsa.
-
Han tar rodret på Siemens Healthcare
Tomas Kramar är vd för det nya bolaget som även rekryterat en försäljningschef.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Mingling do's and don'ts
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Tre diagnostikbolag slås ihop
Almi Invest investerar i en svensk-finsk företagsfusion med målet att få fram produkter för snabbare och säkrare analyssvar i sjukvården.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Sanionas kokainstudie inledd
Bioteknikföretagets samarbetspartner TRC har påbörjat rekrytering till studien om kokainberoende.
BREAKING